Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-12

Clinical Trial Update: CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Cardiosphere-Derived Autologous Stem Cells for reversing ventricular dysfunction in patients with recent myocardial infarction has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cardiosphere-Derived Autologous Stem Cells

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Recent Myocardial Infarction, Ventricular Dysfunction | Phase 1 | Status: COMPLETED